ARTICLE | Targets & Mechanisms
Emerging immuno-oncology mechanisms at ASH 2019
Immune system biomarkers take center stage among emerging targets at ASH 2019
December 6, 2019 3:53 AM UTC
Updated on Dec 6, 2019 at 4:07 AM UTC
Researchers are finding new ways to monitor the immune system in hematologic diseases that could have implications for optimizing immuno-oncology therapies, according to BioCentury’s analysis of emerging targets at ASH 2019.
In abstracts released ahead of this year’s meeting of the American Society of Hematology (ASH), BioCentury identifies 25 emerging targets, 12 of which are involved in immunity...